butyric acid has been researched along with Pancreatic Neoplasms in 18 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously demonstrated that two human pancreatic adenocarcinoma cell lines, CFPAC-1 (established from a patient with cystic fibrosis) and CAPAN-1, were able to secrete trypsinogens 1 and 2 specifically." | 3.69 | Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1. Modulation during spontaneous and induced cell growth. ( Figarella, C; Guy-Crotte, O; Merten, M; Miszczuk-Jamska, B; Renaud, W, 1994) |
| " In this study we examined the effects of two agents that promote cellular differentiation, sodium butyrate and hexamethylene bisacetamide, on the in vitro growth and secretory responses of a human pancreatic carcinoid (BON) and human gastrinoma (PT-2 and PT-SM) cell lines that have been established in our laboratory." | 3.68 | Differential effects of sodium butyrate and hexamethylene bisacetamide on growth and secretion of cultured human endocrine tumor cells. ( Beauchamp, RD; Haber, BE; Hsieh, J; Ishizuka, J; Karp, G; Parekh, D; Rajaraman, S; Thompson, JC; Townsend, CM, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Sanaei, M | 1 |
| Kavoosi, F | 1 |
| Almaraz, RT | 1 |
| Aich, U | 1 |
| Khanna, HS | 1 |
| Tan, E | 1 |
| Bhattacharya, R | 1 |
| Shah, S | 1 |
| Yarema, KJ | 1 |
| Green, R | 1 |
| Shields, D | 1 |
| McIntyre, LJ | 1 |
| Kim, YS | 2 |
| Miszczuk-Jamska, B | 1 |
| Merten, M | 1 |
| Renaud, W | 1 |
| Guy-Crotte, O | 1 |
| Figarella, C | 1 |
| Corra, S | 1 |
| Kazakoff, K | 1 |
| Mogaki, M | 1 |
| Cano, M | 1 |
| Pour, PM | 1 |
| Swarovsky, B | 1 |
| Eissele, R | 1 |
| Eisenacher, M | 1 |
| Trautmann, ME | 2 |
| Arnold, R | 1 |
| Fernandez-Mejia, C | 1 |
| Davidson, MB | 1 |
| Egawa, N | 1 |
| Maillet, B | 1 |
| VanDamme, B | 1 |
| De Grève, J | 1 |
| Klöppel, G | 1 |
| Estival, A | 1 |
| Clerc, P | 1 |
| Vaysse, N | 1 |
| Tam, JP | 1 |
| Clemente, F | 1 |
| Parekh, D | 1 |
| Ishizuka, J | 1 |
| Townsend, CM | 1 |
| Haber, BE | 1 |
| Beauchamp, RD | 1 |
| Rajaraman, S | 1 |
| Karp, G | 1 |
| Hsieh, J | 1 |
| Thompson, JC | 1 |
| Mullins, TD | 1 |
| Kern, HF | 1 |
| Metzgar, RS | 1 |
| Blondel, B | 1 |
| Gjinovci, A | 1 |
| Wollheim, CB | 1 |
| Bartholomeusz, RK | 1 |
| Campbell, IL | 1 |
| Harrison, LC | 1 |
| Gardner, SL | 1 |
| Dotta, F | 1 |
| Nayak, RC | 1 |
| George, KL | 1 |
| Eisenbarth, GS | 1 |
| Halban, PA | 1 |
| Bloom, EJ | 1 |
| Siddiqui, B | 1 |
| Hicks, JW | 1 |
| Bryant, G | 1 |
| Haberern, C | 1 |
| Rao, CN | 1 |
| Liotta, LA | 1 |
| el-Deriny, SE | 1 |
| O'Brien, MJ | 1 |
| Christensen, TG | 1 |
| Kupchik, HZ | 1 |
18 other studies available for butyric acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
Effect of Sodium Butyrate on p16INK4a, p14ARF, p15INK4b, Class I HDACs (HDACs 1, 2, 3) Class II HDACs (HDACs 4, 5, 6), Cell Growth Inhibition and Apoptosis Induction in Pancreatic Cancer AsPC-1 and Colon Cancer HCT-116 Cell Lines.
Topics: Apoptosis; Butyric Acid; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent | 2022 |
Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.
Topics: Acylation; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Azides; Breast Neoplasms; Buty | 2012 |
Sodium butyrate stimulates somatostatin production by cultured cells.
Topics: Adenoma, Islet Cell; Animals; Butyrates; Butyric Acid; Cell Line; HeLa Cells; Humans; Insulinoma; Ki | 1984 |
Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines.
Topics: Agar; Alkaline Phosphatase; Amylases; Butyrates; Butyric Acid; Cell Adhesion; Cell Division; Cell Li | 1984 |
Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1. Modulation during spontaneous and induced cell growth.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Division; Dexamethasone; Dimethyl Sulfoxide; Humans; P | 1994 |
Modification of antigen expression in human and hamster pancreatic cancer cell lines induced by sodium butyrate.
Topics: ABO Blood-Group System; Adenocarcinoma; Animals; Antigens, Neoplasm; Blood Group Antigens; Butyrates | 1993 |
Sodium butyrate induces neuroendocrine cytodifferentiation in the insulinoma cell line RINm5F.
Topics: Blotting, Northern; Butyrates; Butyric Acid; Cell Differentiation; Chromogranin A; Chromogranins; Cy | 1994 |
Effect of sodium butyrate on glucose transport and glucose-phosphorylating enzymes in RIN-m5F cells.
Topics: Animals; Biological Transport; Butyrates; Butyric Acid; Cell Division; Glucokinase; Glucose; Glucose | 1993 |
Differentiation of pancreatic carcinoma induced by retinoic acid or sodium butyrate: a morphological and molecular analysis of four cell lines.
Topics: Blotting, Northern; Blotting, Western; Butyrates; Butyric Acid; Carcinoma, Ductal, Breast; CD57 Anti | 1996 |
Decreased expression of transforming growth factor alpha during differentiation of human pancreatic cancer cells.
Topics: Butyrates; Butyric Acid; Cell Differentiation; Gene Expression Regulation; Humans; Pancreatic Neopla | 1992 |
Differential effects of sodium butyrate and hexamethylene bisacetamide on growth and secretion of cultured human endocrine tumor cells.
Topics: 5-Hydroxytryptophan; Acetamides; Analysis of Variance; Butyrates; Butyric Acid; Carcinoid Tumor; Cel | 1991 |
Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
Topics: Adenocarcinoma; Alkaline Phosphatase; Butyrates; Butyric Acid; Cell Division; Cell Transformation, N | 1991 |
Inverse relationship between glucose metabolism and glucose-induced insulin secretion in rat insulinoma cells.
Topics: Animals; Butyrates; Butyric Acid; Cell Line; Dose-Response Relationship, Drug; Glucose; Glyceraldehy | 1990 |
Pancreatic islet A2B5- and 3G5-reactive gangliosides are markers of differentiation in rat insulinoma cells.
Topics: Adenoma, Islet Cell; Animals; Antibodies, Monoclonal; Butyrates; Butyric Acid; Cell Differentiation; | 1989 |
Modulation by sodium butyrate of the differentiated status of a clonal pancreatic B-cell line (RIN).
Topics: Animals; Antibodies, Monoclonal; Autoantibodies; Butyrates; Butyric Acid; Cell Differentiation; Cell | 1989 |
Effect of sodium butyrate, a differentiating agent, on cell surface glycoconjugates of a human pancreatic cell line.
Topics: Butyrates; Butyric Acid; Cell Division; Cell Line; Cell Membrane; Cell Transformation, Neoplastic; G | 1989 |
Butyrate induced reduction of tumor cell laminin receptors.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Gene Expression Regulation | 1986 |
Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Carcinoembryonic Antigen; Cell Differentiation; Cell Divisi | 1987 |